专题：Neuroendocrine Tumor Research Advances

This cluster of papers focuses on the epidemiology, classification, management, and treatment of neuroendocrine tumors, with a specific emphasis on pancreatic neuroendocrine tumors. It covers topics such as somatostatin receptor-based imaging and therapy, MEN1 syndrome, peptide receptor radionuclide therapy, genetic mutations associated with these tumors, and survival analysis.
最新文献
Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer

article Full Text OpenAlex

The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma

article Full Text OpenAlex

Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation

article Full Text OpenAlex

EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm

article Full Text OpenAlex

The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours

article Full Text OpenAlex

[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study

article Full Text OpenAlex

Structural basis and selectivity of sulfatinib binding to FGFR and CSF-1R

article Full Text OpenAlex

Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review

article Full Text OpenAlex

Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study

article Full Text OpenAlex

Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers

review Full Text OpenAlex

近5年高被引文献
Small-cell lung cancer

review Full Text OpenAlex 1351 FWCI104.93632508

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

review Full Text OpenAlex 1073 FWCI77.88979973

Overview of the 2022 WHO Classification of Thyroid Neoplasms

review Full Text OpenAlex 940 FWCI198.41047889

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

article Full Text OpenAlex 827 FWCI67.19698739

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 809 FWCI181.33265954

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

article Full Text OpenAlex 768 FWCI161.12952904

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

review Full Text OpenAlex 766 FWCI115.89453282

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

article Full Text OpenAlex 726 FWCI55.5606916

The Next Decade of Immune Checkpoint Therapy

review Full Text OpenAlex 697 FWCI58.91529939

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

article Full Text OpenAlex 601 FWCI90.71949934